We are live on ! Find out more
SP

SIH Partners Portfolio holdings

AUM $7.58B
1-Year Est. Return 5.28%
This Fund
S&P 500
This Quarter Est. Return
+0.43%
1 Year Est. Return
+5.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.95B
AUM Growth
+$974M
Cap. Flow
+$1.05B
Cap. Flow %
35.62%
Top 10 Hldgs %
65.51%
Holding
315
New
184
Increased
39
Reduced
33
Closed
45

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.41%
2 Financials 5.13%
3 Healthcare 5.02%
4 Communication Services 1.71%
5 Materials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
251
Ardelyx
ARDX
$1.25B
$66.3K ﹤0.01%
+13,497
New +$72.5K
GERN icon
252
Geron
GERN
$949M
$63.4K ﹤0.01%
+39,868
New +$97.1K
NGD
253
DELISTED
New Gold Inc
NGD
$51.5K ﹤0.01%
13,895
+3,159
+29% +$9.36K
DNN icon
254
Denison Mines
DNN
$2.64B
$46.6K ﹤0.01%
+35,873
New +$59.9K
ABUS icon
255
Arbutus Biopharma
ABUS
$871M
$43K ﹤0.01%
+12,318
New +$41.1K
CVAC
256
DELISTED
CureVac
CVAC
$40.2K ﹤0.01%
+14,507
New +$50.5K
ABCL icon
257
AbCellera Biologics
ABCL
$1.6B
$38.3K ﹤0.01%
+17,163
New +$49.2K
SVRA icon
258
Savara
SVRA
$1.11B
$30K ﹤0.01%
+10,847
New +$30K
PGEN icon
259
Precigen
PGEN
$1.93B
$28.6K ﹤0.01%
+19,203
New +$30.2K
BFLY icon
260
Butterfly Network
BFLY
$1.85B
$24.1K ﹤0.01%
+10,557
New +$37.7K
ERAS icon
261
Erasca
ERAS
$6.55B
$23.4K ﹤0.01%
+17,067
New +$29.3K
SANA icon
262
Sana Biotechnology
SANA
$913M
$22.6K ﹤0.01%
+13,427
New +$37.5K
CERS icon
263
Cerus
CERS
$615M
$21.7K ﹤0.01%
+15,602
New +$26.1K
UROY
264
Uranium Royalty Corp
UROY
$402M
$21.6K ﹤0.01%
+12,245
New +$26.2K
ALLO icon
265
Allogene Therapeutics
ALLO
$604M
$20.1K ﹤0.01%
+13,747
New +$25.9K
TSHA icon
266
Taysha Gene Therapies
TSHA
$1.59B
$16.9K ﹤0.01%
+12,173
New +$20.4K
ESPR
267
DELISTED
Esperion Therapeutics
ESPR
$16.4K ﹤0.01%
+11,411
New +$21K
QSI icon
268
Quantum-Si Incorporated
QSI
$171M
$12.7K ﹤0.01%
+10,624
New +$20.4K
TVGN icon
269
Tevogen Bio Holdings
TVGN
$23.5M
$11.4K ﹤0.01%
+211
New +$13.9K
LXRX icon
270
Lexicon Pharmaceuticals
LXRX
$991M
$10.9K ﹤0.01%
+23,712
New +$15K
AAPL icon
271
Apple
AAPL
$4.95T
-11,458
Closed -$2.65M
ADTN icon
272
Adtran
ADTN
$769M
-12,846
Closed -$107K
ALL icon
273
CALL
Allstate
ALL
$67.3B
-17,700
Closed -$3.41M
ALL icon
274
PUT
Allstate
ALL
$67.3B
-24,000
Closed -$4.63M
AMD icon
275
Advanced Micro Devices
AMD
$807B
-11,196
Closed -$1.35M

Similar funds

SIH Partners's Q1 2025 Portfolio in Review

As of Q1 2025, SIH Partners held 315 positions worth $2.95B, up 49% from $1.98B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

SIH Partners deployed $1.05B of net new capital in Q1 2025, opening 184 new positions and adding to 39 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,828,497 shares worth $124M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $115M trimmed.

  • SIH Partners's largest Q1 2025 buy was iShares MSCI Emerging Markets ETF: 2,828,497 shares worth $124M.
  • SIH Partners added most to Stellantis in Q1 2025, an estimated $38.7M increase.
  • SIH Partners's biggest Q1 2025 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $115M.
  • SIH Partners fully exited State Street SPDR S&P 500 ETF Trust in Q1 2025, selling an estimated $263M.
  • SIH Partners's ten largest holdings make up 66% of its $2.95B portfolio in Q1 2025.
  • SIH Partners opened 184 new positions and closed 45 in Q1 2025.
  • SIH Partners's portfolio value rose 49% quarter-over-quarter to $2.95B.

Based on SIH Partners's 13F filing for Q1 2025, filed 15 May 2025.